Please login to the form below
24
Revenue 2017Daiichi Sankyo
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.
AZ strengthens Daiichi Sankyo partnership with new ADC deal
Deal for experimental antibody drug conjugate could reach $6bn. AstraZeneca (AZ) has invested up to $6bn in a new partnership with Japanese pharma company Daiichi Sankyo (Daiichi) for the development of ... We are delighted to enter this new
Merck expands partnership with Zymeworks for multispecific antibodies
Aside from Merck, Zymeworks has inked deals with a number of major pharma companies, including Eli Lilly, Celgene, GlaxoSmithKline and Daiichi Sankyo.
EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug
Antibody drug conjugate gained approval in US in December. The European Medicines Agency (EMA) has accelerated the assessment of Daiichi Sankyo and AstraZeneca’s HER2-positive breast cancer candidate, fast-tracking ... Trastuzumab deruxtecan is central
Cortellis Drugs to Watch in 2020 report
10. Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) is also an ADC that targets HER2.
Seattle Genetics wins FDA priority review for oral HER2 drug
If approved will compete with AZ/Daiichi Sankyo's Enhertu. Seattle Genetics has scored a US Food and Drug Administration (FDA) priority review for its oral HER2 inhibitor tucatinib in breast ... If Seattle does gain approval for tucatinib, it will go on
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
- Novartis and smartpatient launch app experience for wet AMD patients
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Pfizer, Mylan move ahead with generics merger and spin-out
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Send Us a Message
- CureVac reveals early data for mRNA-based COVID-19 vaccine candidate
- Laurence Bannister joins Lucid Group as its new Chief Commercial Officer
- AZ’s COVID-19 vaccine demonstrates efficacy rate of up to 90%
- UK could approve Pfizer’s COVID-19 vaccine this week
- Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval
- Power to the patient: digital innovation supporting patients with chronic diseases
- New from the PhRMA: Diversity in clinical trials principles summarised
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- New from the PhRMA: Diversity in clinical trials principles summarised
- In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
- New from the FDA: Diversity in clinical trials guidance summarised
- In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
- 5 steps to effective clinical trial branding
- When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...
Quick links
Infographics
